Abstract: This work will develop the capability to spatially detect a wide range of metabolites quantitatively and in real- time within a single cell. Few techniques are available to measure metabolite concentrations, although they are a key indicator of a cell's genomic expression, and the capability of metabolite flux measurements, resolved spatially and transiently, is heretofore unrealized. This project will provide these abilities to benefit several fields, including metabolomics, functional genomics, toxicology, cancer biology, metabolic engineering, and clinical diagnostics. The sensors will consist of single-walled carbon nanotubes which emit photostable near-infrared fluorescence which is highly environmentally sensitive. The nanotubes will be functionalized with ligands which bind to important metabolites and the binding event will be transduced by spectral shifts in the nanotube's emission. The investigator's group will introduce these nanotube sensors into live cells in order to answer important questions relevant to cancer biology and cell metabolism. Concomitantly, the team will work towards the rapid and real-time detection of clinically-relevant metabolites for early cancer diagnosis and the benchmarking of metastasis. We will also re-construct multiplexed metabolite data in order to conduct single- cell metabolomic fingerprinting. Public Health Relevance: Metabolites are small molecules produced in the body which may be used in the future to detect cancer at earlier stages, better understand the biology of cancer, and improve the development of important drugs. This project develops sensors using nanomaterials to detect many classes of metabolites within single cells and in human tissues.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
NIH Director’s New Innovator Awards (DP2)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-NDIA-C (01))
Program Officer
Grave, Gilman D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
Shamay, Yosi; Shah, Janki; I??k, Mehtap et al. (2018) Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater 17:361-368
Williams, Ryan M; Shah, Janki; Tian, Helen S et al. (2018) Selective Nanoparticle Targeting of the Renal Tubules. Hypertension 71:87-94
Williams, Ryan M; Lee, Christopher; Galassi, Thomas V et al. (2018) Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. Sci Adv 4:eaaq1090
Budhathoki-Uprety, Januka; Langenbacher, Rachel E; Jena, Prakrit V et al. (2017) A Carbon Nanotube Optical Sensor Reports Nuclear Entry via a Noncanonical Pathway. ACS Nano 11:3875-3882
Jena, Prakrit V; Roxbury, Daniel; Galassi, Thomas V et al. (2017) A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux. ACS Nano 11:10689-10703
Jena, Prakrit V; Safaee, Mohammad M; Heller, Daniel A et al. (2017) DNA-Carbon Nanotube Complexation Affinity and Photoluminescence Modulation Are Independent. ACS Appl Mater Interfaces 9:21397-21405
Galassi, Thomas V; Jena, Prakrit V; Roxbury, Daniel et al. (2017) Single Nanotube Spectral Imaging To Determine Molar Concentrations of Isolated Carbon Nanotube Species. Anal Chem 89:1073-1077
Mizrachi, Aviram; Shamay, Yosi; Shah, Janki et al. (2017) Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma. Nat Commun 8:14292
Sims, Christopher M; Hanna, Shannon K; Heller, Daniel A et al. (2017) Redox-active nanomaterials for nanomedicine applications. Nanoscale 9:15226-15251
Scheinberg, David A; Grimm, Jan; Heller, Daniel A et al. (2017) Advances in the clinical translation of nanotechnology. Curr Opin Biotechnol 46:66-73

Showing the most recent 10 out of 19 publications